Latest Insider Transactions at Cerevel Therapeutics Holdings, Inc. (CERE)
This section provides a real-time view of insider transactions for Cerevel Therapeutics Holdings, Inc. (CERE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cerevel Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cerevel Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$2,100,000
$42.24 P/Share
|
|
Jan 02
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Dec 26
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.53%
|
$420,000
$42.47 P/Share
|
|
Dec 26
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.84%
|
$30,000
$3.5 P/Share
|
|
Dec 26
2023
|
Kathleen Tregoning |
BUY
Exercise of conversion of derivative security
|
Direct |
3,150
+22.8%
|
$31,500
$10.05 P/Share
|
|
Dec 22
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
8,000
-24.49%
|
$328,000
$41.45 P/Share
|
|
Dec 22
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+19.67%
|
$24,000
$3.5 P/Share
|
|
Dec 20
2023
|
Mark Bodenrader |
SELL
Open market or private sale
|
Direct |
7,889
-30.8%
|
$323,449
$41.42 P/Share
|
|
Dec 20
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,072
-49.42%
|
$289,952
$41.42 P/Share
|
|
Dec 20
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,256
-20.23%
|
$256,496
$41.42 P/Share
|
|
Dec 20
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,152
-40.89%
|
$416,232
$41.42 P/Share
|
|
Dec 20
2023
|
Kathleen Tregoning |
SELL
Open market or private sale
|
Direct |
6,288
-45.55%
|
$257,808
$41.42 P/Share
|
|
Dec 20
2023
|
Susan Altschuller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,808
-44.95%
|
$566,128
$41.42 P/Share
|
|
Dec 19
2023
|
Paul D. Burgess |
BUY
Exercise of conversion of derivative security
|
Direct |
23,847
+34.28%
|
-
|
|
Dec 19
2023
|
Mark Bodenrader |
BUY
Exercise of conversion of derivative security
|
Direct |
19,284
+28.73%
|
-
|
|
Dec 19
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,796
+49.09%
|
-
|
|
Dec 19
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,913
+31.03%
|
-
|
|
Dec 19
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,825
+50.0%
|
-
|
|
Dec 19
2023
|
Ronald C Renaud Jr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
160,452
+50.0%
|
-
|
|
Dec 19
2023
|
Kathleen Tregoning |
BUY
Exercise of conversion of derivative security
|
Direct |
13,804
+50.0%
|
-
|
|
Dec 19
2023
|
Susan Altschuller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,721
+50.0%
|
-
|
|
Dec 15
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$307,500
$41.39 P/Share
|
|
Dec 15
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$67,500
$9.88 P/Share
|
|
Dec 07
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$410,000
$41.37 P/Share
|
|
Dec 07
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.5 P/Share
|
|
Dec 07
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-95.12%
|
$410,000
$41.37 P/Share
|
|
Dec 07
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+48.75%
|
$130,000
$13.17 P/Share
|
|
Dec 05
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-93.6%
|
$262,500
$35.0 P/Share
|
|
Dec 05
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+48.35%
|
$97,500
$13.17 P/Share
|
|
Nov 14
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
22,824
-89.41%
|
$570,600
$25.13 P/Share
|
|
Nov 14
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
22,824
+47.2%
|
$68,472
$3.5 P/Share
|
|
Nov 08
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
100
-3.57%
|
$2,500
$25.16 P/Share
|
|
Nov 08
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+3.44%
|
$300
$3.5 P/Share
|
|
Nov 07
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
27,076
-90.92%
|
$676,900
$25.02 P/Share
|
|
Nov 07
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
27,076
+47.62%
|
$81,228
$3.5 P/Share
|
|
Nov 03
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
61,401
-95.78%
|
$1,535,025
$25.43 P/Share
|
|
Nov 03
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
61,401
+48.92%
|
$184,203
$3.5 P/Share
|
|
Nov 02
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
38,599
-93.45%
|
$964,975
$25.19 P/Share
|
|
Nov 02
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
38,599
+48.31%
|
$115,797
$3.5 P/Share
|
|
Nov 01
2023
|
Deval L Patrick |
SELL
Open market or private sale
|
Direct |
30,130
-90.18%
|
$753,250
$25.0 P/Share
|
|
Nov 01
2023
|
Deval L Patrick |
BUY
Exercise of conversion of derivative security
|
Direct |
30,130
+47.42%
|
$361,560
$12.62 P/Share
|
|
Oct 16
2023
|
Bain Capital Investors LLC |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Adam Koppel |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Christopher R Gordon |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
876,808
+7.51%
|
$19,289,776
$22.81 P/Share
|
|
Sep 07
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,200,000
$24.07 P/Share
|
|
Sep 07
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Aug 04
2023
|
Paul D. Burgess |
BUY
Open market or private purchase
|
Direct |
21,880
+50.0%
|
$481,360
$22.93 P/Share
|
|
Aug 03
2023
|
Ronald C Renaud Jr President & CEO |
BUY
Open market or private purchase
|
Indirect |
83,857
+50.0%
|
$1,928,711
$23.96 P/Share
|
|
Jul 11
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,500,000
$30.03 P/Share
|